SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In
 
We’re going down soon, to move to a new Data Center today.  We’ll be up ASAP.  Sorry.

Aesthetic Medical International Holdings Group Ltd – IPO: ‘F-1’ on 9/30/19 – ‘EX-23.5’

On:  Monday, 9/30/19, at 5:14pm ET   ·   Accession #:  1047469-19-5529   ·   File #:  333-234022

Previous ‘F-1’:  None   ·   Next:  ‘F-1/A’ on 10/15/19   ·   Latest:  ‘F-1/A’ on 10/23/19   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/30/19  Aesthetic Medical Int’l Hold… Ltd F-1                   23:9.3M                                   Merrill Corp/New/FA

Initial Public Offering (IPO):  Registration Statement by a Foreign Issuer   —   Form F-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-1         Registration Statement by a Foreign Issuer          HTML   3.81M 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML    296K 
 3: EX-4.1      Instrument Defining the Rights of Security Holders  HTML    361K 
 4: EX-4.4      Instrument Defining the Rights of Security Holders  HTML    385K 
 5: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     24K 
 6: EX-4.7      Instrument Defining the Rights of Security Holders  HTML     78K 
 7: EX-5.1      Opinion of Counsel re: Legality                     HTML     16K 
 8: EX-8.1      Opinion of Counsel re: Tax Matters                  HTML     15K 
 9: EX-8.3      Opinion of Counsel re: Tax Matters                  HTML     14K 
10: EX-10.1     Material Contract                                   HTML     57K 
11: EX-10.2     Material Contract                                   HTML     57K 
12: EX-10.3     Material Contract                                   HTML     20K 
13: EX-10.4     Material Contract                                   HTML     63K 
14: EX-10.5     Material Contract                                   HTML     61K 
15: EX-10.6     Material Contract                                   HTML     62K 
16: EX-21.1     Subsidiaries                                        HTML     23K 
17: EX-23.1     Consent of Experts or Counsel                       HTML      9K 
18: EX-23.5     Consent of Experts or Counsel                       HTML     12K 
19: EX-23.6     Consent of Experts or Counsel                       HTML     10K 
20: EX-23.7     Consent of Experts or Counsel                       HTML     10K 
21: EX-23.8     Consent of Experts or Counsel                       HTML     10K 
22: EX-99.1     Miscellaneous Exhibit                               HTML     48K 
23: EX-99.2     Miscellaneous Exhibit                               HTML     95K 


‘EX-23.5’   —   Consent of Experts or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 23.5

 

Aesthetic Medical International Holdings Group Limited

1122 Nanshan Boulevard

Nanshan District, Shenzhen

Guangdong Province, China

 

Re: Aesthetic Medical International Holdings Group Limited

 

Ladies and Gentlemen,

 

We understand that Aesthetic Medical International Holdings Group Limited (the “Company”) plans to file a registration statement on Form F-1 (the “Registration Statement”) with the United States Securities and Exchange Commission (the “SEC”) in connection with its proposed public offering (the “Proposed Offering”).

 

We hereby consent to the references to our name and the inclusion of information, data and statements from our research reports and amendments thereto (collectively, the “Reports”), and any subsequent amendments to the Reports, as well as the citation of our research reports and amendments thereto, in the Registration Statement and any amendments thereto, in any other future filings with the SEC by the Company, including, without limitation, filings on Form 20-F or Form 6-K or other SEC filings (collectively, the “SEC Filings”), on the websites of the Company and its subsidiaries and affiliates, in institutional and retail road shows and other activities in connection with the Proposed Offering, and in other publicity materials in connection with the Proposed Offering.

 

We further hereby consent to the filing of this letter as an exhibit to the Registration Statement and any amendments thereto and as an exhibit to any other SEC Filings.

 

Yours faithfully,

 

For and on behalf of

Frost & Sullivan (Beijing) Inc., Shanghai Branch Co.

 

/s/ Yves Wang

 

Name: Yves Wang

 

Title: Managing Director, China

 

 

 

Date: September 30, 2019

 

 




Dates Referenced Herein

This ‘F-1’ Filing    Date    Other Filings
Filed on:9/30/19None on these Dates
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/25/24  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/23  173:23M                                    Toppan Merrill/FA
 4/21/23  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/22  177:24M                                    Toppan Merrill/FA
 6/17/22  Aesthetic Medical Int’l Hold… Ltd F-3                    5:591K                                   Toppan Merrill/FA
 5/16/22  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/21  186:28M                                    Toppan Merrill/FA
 4/30/21  Aesthetic Medical Int’l Hold… Ltd 20-F       12/31/20  206:35M                                    Toppan Merrill/FA
10/07/19  SEC                               UPLOAD11/22/19    2:43K  Aesthetic Medical Int’l Hold… Ltd
Top
Filing Submission 0001047469-19-005529   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 11, 10:28:03.2am ET